Pharmacy benefit managers are moving beyond formulary access to provide support programs for women's health. Here's how three PBMs — Judi Health, LucyRx and RxPreferred — are putting that strategy into practice.
News|Articles|September 1, 2003
Fondaparinux effective and well-tolerated for prevention of VTE in acutely ill patients
Fondaparinux (Arixtra, Organon/Sanofi-Synthelabo) given once daily significantly reduces the risk of venous thromboembolism (VTE) in acutely ill, hospitalized patients, according to data from the Arixtra for ThromboEmbolism prevention in a Medical Indications Study (ARTEMIS).
Advertisement
Advertisement
Related to this article
Women face more gaps in healthcare than men, from missed screenings, undertreatment and biased coverage. PBMs are launching programs to address some of the gaps.
Navitus launched three modular options that let plan sponsors manage diabetes, weight, and lifestyle therapy access, cost, and outcomes with guaranteed ROI.
StarkRx has launched as a modular, cost-plus pharmacy benefit management company for self-funded employers using Judi Health’s PBM, Judi Rx, to administer claims.
Advertisement
Advertisement